Dr. Mattson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
355 West 16th Street
#4700
Indianapolis, IN 46202Phone+1 317-948-5450- Is this information wrong?
Education & Training
- Clinical Center at the National Institutes of HealthResidency, Neurology, 1986 - 1989
- University of Pennsylvania Health SystemResidency, Neurology, 1983 - 1986
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1982 - 1983
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1982
Certifications & Licensure
- IN State Medical License 1997 - 2025
- PA State Medical License 1983 - 1990
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
- Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 17 citationsSystemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis.Melissa Tully, Jonathan Tang, Lingxing Zheng, Glen Acosta, Ran Tian, Lee Hayward, Nicholas Race, David Mattson, Riyi Shi> ;Frontiers in Neurology. 2018 Jun 15
- 43 citationsSafety/tolerability of the anti-semaphorin 4D antibody VX15/2503 in a randomized phase 1 trialChristopher LaGanke, Lawrence Samkoff, Keith R. Edwards, Lily K. Jung Henson, Pavle Repovic, Sharon G. Lynch, Lael Stone, David Mattson, Aaron Galluzzi, Terrence L. Fi...> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2017 Jun 16
- Mutation of SH2B3 (LNK), a Genome-Wide Association Study Candidate for Hypertension, Attenuates Dahl Salt-Sensitive Hypertension via Inflammatory Modulation.Rudemiller, N. P.,Lund, H.,Priestley, J. R.,Endres, B. T.,Prokop, J. W.,Jacob, H. J.,Geurts, A. M.,Cohen, E. P.,Mattson, D. L.> ;Hypertension. 2015 Mar 18
- Join now to see all
Press Mentions
- Marquette University Biomedical Engineering Professor Receives $3.34 Million R01 Grant to Study Improved Mobility for Those With Multiple SclerosisOctober 11th, 2022
- Possible Biomarker for Multiple Sclerosis IdentifiedDecember 19th, 2018
Professional Memberships
- Member
Hospital Affiliations
- Eskenazi HealthIndianapolis, Indiana
- Indiana University Health University HospitalIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: